SADI-S and Duodenal Switch: How malabsorptive procedures work

The sleeve gastrectomy is the most commonly performed bariatric procedure in the United States, and for good reason. It’s effective, recovery is manageable, and the risks are well-understood. But for some patients — particularly those with a higher starting BMI or more serious metabolic disease — the sleeve simply doesn’t go far enough. That’s where procedures like SADI-S and the Duodenal Switch come in.

These are the most powerful surgical tools in bariatric medicine. They consistently outperform the sleeve on weight loss, diabetes remission, and long-term durability. They also come with greater complexity, longer recovery, and lifelong nutritional management requirements. Understanding the difference is how you and your surgeon figure out which option is right for you.

The short answer: SADI-S and Duodenal Switch achieve greater weight loss than sleeve gastrectomy because they combine stomach reduction with intestinal bypass, creating both restriction and malabsorption. The sleeve limits how much you eat. These procedures also reduce how many calories your body absorbs. For patients with BMIs in the upper 40s or higher, that combined effect is often what makes the difference between durable long-term results and eventual regain.

—

How Sleeve Gastrectomy Works — and Where It Has Limits

Sleeve gastrectomy permanently removes roughly 80% of the stomach, reshaping what remains into a narrow tube about the size of a banana. The result is a dramatic reduction in stomach capacity, which limits portion size, reduces hunger hormone production, and typically produces significant weight loss in the first one to two years.

What the sleeve doesn’t do is alter digestion. Food still travels through the full length of the small intestine, and the body absorbs calories and nutrients the same way it always has. That’s what makes the sleeve predictable and lower-risk — and also what limits its ceiling. For patients with severe obesity or complex metabolic disease, that ceiling can become a problem.

Weight regain is more common with sleeve gastrectomy than with malabsorptive procedures, and diabetes resolution — while meaningful — tends to be less durable, especially in patients with long-standing or more severe disease. That’s not a failure of the sleeve. It’s the biology of restriction-only surgery.

—

What Is SADI-S?

SADI-S stands for Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy. It starts with a sleeve gastrectomy, then adds a bypass of a significant portion of the small intestine by connecting the first segment of the small intestine (the duodenum) directly to a lower segment (the ileum). “Anastomosis” simply refers to that surgical connection.

By skipping a large section of the small intestine, SADI-S creates a more direct route from the stomach to the colon. Food that would normally travel the full length of the small intestine — absorbing calories, fat, and nutrients along the way — reaches the colon much faster, with far less time and intestinal surface area available for absorption. That’s what malabsorption actually means in practice: not that digestion stops, but that the shortcut limits how much the body can extract from what you eat. That effect adds a second mechanism for weight loss on top of the restriction from the sleeve, and produces stronger metabolic results than restriction alone can achieve.

The “single anastomosis” part matters clinically. Creating one surgical connection instead of two simplifies the procedure, reduces operative time, and lowers complication risk compared to the more complex Duodenal Switch — while retaining most of its metabolic benefits. That trade-off makes SADI-S the preferred option in many cases where we want more power than the sleeve but don’t need the full DS.

Research supports that advantage. Published data shows SADI-S achieving 69 to 86% excess weight loss at one to two years after surgery, with results holding to approximately 76% at six to nine years [PMC, 2023; PMC, 2024]. In patients who had a sleeve and needed a revision, SADI-S outperformed other revision options [PubMed/Obesity Surgery, 2021].

—

What Is Duodenal Switch?

The Duodenal Switch — formally called Biliopancreatic Diversion with Duodenal Switch, or BPD-DS — is the most powerful bariatric procedure available. Like SADI-S, it begins with a sleeve gastrectomy and then reroutes the small intestine to create malabsorption. The difference is in the architecture: DS creates two anastomoses rather than one, resulting in a greater degree of intestinal bypass and more profound malabsorption.

The intestinal rerouting in DS divides the small intestine into two separate limbs. One carries food from the stomach. The other carries digestive fluids from the liver and pancreas. These two streams travel separately for most of their length and only merge in the final stretch before the colon — meaning food spends very little time in contact with digestive enzymes, and the intestinal surface available for calorie and fat absorption is drastically reduced. It’s a more aggressive shortcut than SADI-S, which is why DS produces the most profound malabsorption of any bariatric procedure.

The results reflect that added complexity. DS achieves 79 to 85% excess BMI loss at two years — among the highest weight loss figures reported in bariatric surgery [JAMA Surgery, 2012]. At two years following sleeve conversion, DS showed 41.7% total weight loss compared to 35.3% for SADI-S, though that gap tends to narrow at longer follow-up [ASMBS, 2021].

The trade-off is complexity. DS increases operative time, carries a higher leak rate (approximately 1.6%), and a higher reoperation rate (approximately 3.3%) compared to simpler procedures [JAMA Surgery, 2012]. Long-term nutritional management is more demanding than with any other bariatric procedure. For the right patient, those trade-offs are worth it. Because of this, we evaluate candidacy carefully.

—

Comparing Weight Loss Outcomes: Sleeve vs. SADI-S vs. DS

The weight loss difference between these procedures isn’t trivial. For a patient with a BMI of 55, a few percentage points of excess weight loss can translate to 20, 30, or 40 pounds over time. That margin matters for quality of life, joint health, and comorbidity resolution.

At two years out, sleeve gastrectomy produces results broadly comparable to gastric bypass in restriction — but DS pulls significantly ahead, achieving 79 to 85% excess weight loss [JAMA Surgery, 2012]. SADI-S sits between them, with most data and our own experience showing it closer to DS than to sleeve in terms of long-term weight maintenance. Where sleeve gastrectomy loses ground over time due to restriction-only mechanics, the malabsorptive procedures hold their results more durably.

SADI-S and DS are also the preferred options for patients with super obesity — a BMI over 50 — where restriction alone is often insufficient to achieve meaningful clinical outcomes [PMC, 2024]. We see this regularly in practice. Patients who had a sleeve, did well initially, then hit a plateau or regained significant weight often have much better outcomes with a malabsorptive revision. This makes converting a sleeve into a SADI a good option for surgical patients who hit a plateau that leaves them short of their weight loss goals.

—

Comorbidity Resolution: Diabetes, Hypertension, and Sleep Apnea

Weight loss alone doesn’t tell the whole story. For many of our patients, the most important outcome isn’t the number on the scale — it’s getting off insulin, lowering blood pressure, or finally sleeping through the night without a CPAP machine.

Both SADI-S and DS consistently outperform sleeve gastrectomy on diabetes resolution. Research shows diabetes remission rates of 76 to 87% with these procedures, compared to lower rates with sleeve gastrectomy alone [PMC, 2023]. SADI-S data shows hypertension resolution rates around 87% and sleep apnea resolution around 75% [PMC, 2024]. The malabsorptive component produces metabolic improvements that go beyond caloric restriction, particularly for patients with well-established insulin resistance.

Sleeve gastrectomy is not without comorbidity benefits — many patients see real improvement in blood sugar, blood pressure, and sleep apnea following sleeve surgery. But for patients with more severe or long-standing conditions, the durability of those improvements tends to be lower than with a malabsorptive procedure [PMC, 2023].

—

Risks and Complications: What the Data Actually Shows

Greater power comes with greater complexity. Sleeve gastrectomy has the shortest operative times, lowest leak rates, and simplest early recovery of the three. SADI-S and DS require more surgical time, carry higher early complication rates, and have longer, more demanding recoveries.

For DS specifically, published data shows a leak rate of approximately 1.6% and a reoperation rate of approximately 3.3% [JAMA Surgery, 2012]. SADI-S compares favorably to DS on operative complexity while retaining most of its metabolic benefits — a key reason it has grown in adoption among surgeons who perform high volumes of advanced bariatric procedures [OAEPublish, 2025].

The longer-term risk picture is more nuanced. Long-term complication rates for SADI-S may not differ significantly from sleeve gastrectomy in experienced hands [PMC, 2023], which makes picking a surgeon like Dr. Brown who is a nationally recognized expert in SADI critical. The decision between procedures is rarely made on short-term risk alone — it’s a calculation that weighs operative complexity against the risks of undertreated severe obesity, and is something we cover extensively during your initial consultation.

—

Nutritional Requirements: A Lifelong Commitment

This is the part of the conversation we spend the most time on with patients considering SADI-S or DS. The same shortcut that limits calorie absorption also limits how much your body absorbs of the vitamins and minerals in what you eat. Without consistent supplementation, deficiencies in zinc, calcium, iron, and fat-soluble vitamins develop — and some of those deficiencies have serious long-term consequences.

SADI-S patients typically need a comprehensive daily supplement regimen to prevent zinc and calcium deficiency, which are among the most common nutritional findings after this procedure [PMC, 2024]. DS patients have more extensive supplementation needs given the greater degree of intestinal bypass. In both cases, annual labs and follow-up with your surgical team are not optional — they’re the thing that determines whether your long-term health outcomes are excellent or problematic. This is why your surgical relationship with Dr. Brown is life long.

We tend to reserve SADI-S and DS for patients with BMIs in the upper 40s or higher. Patients who are highly motivated, understand what’s involved, and have the support structure to manage long-term follow-up tend to do extremely well. Patients who aren’t ready for that level of commitment are better served by a procedure that’s a closer match to where they are right now.

—

Who Is a Candidate for SADI-S or Duodenal Switch?

Candidacy for these procedures is evaluated on multiple factors, not BMI alone. That said, BMI is a useful starting point.

Patients with BMIs in the upper 40s or higher are often better served by a procedure with a malabsorptive component, because restriction alone is unlikely to produce the clinical outcomes they need. Patients with a BMI over 50 are a population where DS in particular has the strongest evidence base for meaningful, durable results [JAMA Surgery, 2012; PMC, 2024].

Patients with severe type 2 diabetes are also strong candidates. The metabolic effects of malabsorptive surgery on insulin resistance go beyond what weight loss alone produces, and diabetes remission rates after SADI-S and DS are among the best reported in bariatric literature [PMC, 2023].

Finally, patients who previously had a sleeve gastrectomy and experienced suboptimal weight loss or significant regain may be candidates for revisional SADI-S. It’s one of the more established revisional options, and published data supports its effectiveness in this setting [PubMed/Obesity Surgery, 2021].

The right answer is always individual. The same BMI with different metabolic history, nutritional baseline, and lifestyle factors can point toward different procedures. This is the conversation that happens in consultation — and it’s worth having.

—

Sources

• [JAMA Surgery, 2012] Analysis of Obesity-Related Outcomes and Bariatric Failure Rates With the Duodenal Switch vs Gastric Bypass for Morbid Obesity. https://jamanetwork.com/journals/jamasurgery/fullarticle/1358524
• [PMC, 2024] Outcomes of Single Anastomosis Duodeno-Ileal Bypass With Sleeve Gastrectomy. https://pmc.ncbi.nlm.nih.gov/articles/PMC11745527/
• [PubMed/Obesity Surgery, 2021] Revisional Laparoscopic SADI-S vs. Duodenal Switch Following Sleeve Gastrectomy. https://pubmed.ncbi.nlm.nih.gov/33982240/
• [OAEPublish, 2025] Robotic single anastomosis duodenal-ileal bypass with sleeve gastrectomy. https://www.oaepublish.com/articles/2574-1225.2024.104
• [ASMBS, 2021] Long-Term Outcomes of Duodenal Switch vs. SADI-S. https://2021.asmbsmeeting.com/abstract/long-term-outcomes-of-duodenal-switch-ds-versus-single-anastomosis-duodeno-ileostomy-with-sleeve-gastrectomy-sadi-s
• [PMC, 2023] Comparative analysis of 5-year efficacy and outcomes of SADI-S. https://pmc.ncbi.nlm.nih.gov/articles/PMC10520093/
• [PMC, 2025] Comparison Between SADI-S and Duodenal Switch. https://pmc.ncbi.nlm.nih.gov/articles/PMC12457536/